Laboratory Question for the Week of May 31, 2021

Laboratory Compliance Question of the Week

Question:

How was 87426 revised?

Answer:

CPT® 87426 was created to report COVID-19 antigen testing utilizing immunofluorescent or immunochromatographic techniques. However, this code was further revised on October 6, 2020, to include reference to “fluorescence immunoassay [FIA].” 87426 Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19]).


This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.